HCPCS codes

22721 HCPCS codes with hospital pricing data in the network.

• HCPCS C1884 — Carotid artery embolic protection filterAI (1773 hospitals, 2,775–21,801 samples)
• HCPCS L8610 — Ophthalmic capsular tension ringAI (1479 hospitals, 2,198–21,485 samples)
• HCPCS J2359 — Olanzapine injection, 10 mgAI (2009 hospitals, 3,035–21,449 samples)
• HCPCS A9698 — Omnipaque oral imaging contrast liquid, 500 mLAI (686 hospitals, 20,596–21,415 samples)
• HCPCS L0172 — Two-piece foam neck collar, ready-madeAI (1778 hospitals, 2,237–21,326 samples)
• HCPCS J0694 — Cefoxitin sodium injection, 2 gram IVAI (2199 hospitals, 6,488–21,212 samples)
• HCPCS J2354 — Octreotide acetate injection, 100 mcg/mLAI (2301 hospitals, 2,371–21,055 samples)
• HCPCS C1877 — Biliary stent, 10 by 40 mmAI (1537 hospitals, 2,438–20,708 samples)
• HCPCS J2312 — Naloxone injection 0.4 mg/mLAI (1863 hospitals, 5,864–20,561 samples)
• HCPCS C1765 — Surgical adhesion barrier film, small incisionAI (1686 hospitals, 8,582–20,471 samples)
• HCPCS G0498 — Initial IV chemotherapy infusion in clinicAI (1390 hospitals, 16,721–20,465 samples)
• HCPCS J0737 — Injection, clindamycin (Baxter)AI (1602 hospitals, 16,420–20,389 samples)
• HCPCS V5267 — Hearing aid supplies and accessoriesAI (415 hospitals, 2,168–20,330 samples)
• HCPCS J0174 — Injection of lecanemab, per milligramAI (1430 hospitals, 19,959–20,310 samples)
• HCPCS J2175 — Meperidine hydrochloride injection, 25 mg per mLAI (2288 hospitals, 4,327–20,266 samples)
• HCPCS A4216 — Sterile water, saline, or dextrose flush, 10 mLAI (1098 hospitals, 9,754–20,230 samples)
• HCPCS J3111 — Romosozumab injection, per milligramAI (1867 hospitals, 16,862–20,066 samples)
• HCPCS Q4100 — Amniotic membrane allograft, 9 x 20 cmAI (1317 hospitals, 2,015–20,042 samples)
• HCPCS H0035 — Mental health partial hospitalization treatmentAI (560 hospitals, 7,823–19,964 samples)
• HCPCS J1335 — Ertapenem sodium injection, 1 gramAI (2345 hospitals, 7,554–19,587 samples)
• HCPCS J2598 — Vasopressin IV infusion, 20 units per mLAI (2124 hospitals, 9,043–19,492 samples)
• HCPCS J2791 — Rho(D) immune globulin, 1500 IU doseAI (1943 hospitals, 7,177–19,390 samples)
• HCPCS V2785 — Donor corneal tissue for DSAEK/DSEK transplantAI (1025 hospitals, 3,380–19,310 samples)
• HCPCS L8000 — Mastectomy braAI (1268 hospitals, 2,643–19,284 samples)
• HCPCS Q5114 — Trastuzumab-dkst (Ogivri) injection, per 10 mgAI (1580 hospitals, 18,085–19,174 samples)
• HCPCS Q0091 — Pap smear screening sample collectionAI (1603 hospitals, 10,073–19,091 samples)
• HCPCS C1786 — Single-chamber rate-responsive pacemakerAI (1795 hospitals, 2,086–19,060 samples)
• HCPCS U0002 — COVID-19 coronavirus test, non-CDC assayAI (1744 hospitals, 13,674–18,858 samples)
• HCPCS J1610 — Glucagon injection, 1 mgAI (2109 hospitals, 3,749–18,770 samples)
• HCPCS J9063 — Mirvetuximab soravtansine injection, per 1 mgAI (1541 hospitals, 18,399–18,687 samples)
• HCPCS G0123 — Cervical cancer screening Pap test, liquid-based collectionAI (1496 hospitals, 14,081–18,617 samples)
• HCPCS P9073 — Pathogen-reduced platelet transfusionAI (2013 hospitals, 11,014–18,529 samples)
• HCPCS J2185 — Meropenem IV injection, 500 mgAI (2380 hospitals, 4,185–18,252 samples)
• HCPCS S2900 — Robotic surgical system useAI (844 hospitals, 13,317–18,141 samples)
• HCPCS A4215 — STERILE NEEDLEAI (740 hospitals, 3,020–18,014 samples)
• HCPCS C9399 — Bridion 200 mg injectionAI (1464 hospitals, 3,695–17,987 samples)
• HCPCS J1611 — Glucagon injection (Fresenius brand)AI (1885 hospitals, 3,810–17,949 samples)
• HCPCS Q9956 — Octafluoropropane microsphere injection, per milliliterAI (1475 hospitals, 7,706–17,903 samples)
• HCPCS G0010 — Hepatitis B vaccine administrationAI (2040 hospitals, 8,846–17,900 samples)
• HCPCS J2790 — Rho(D) immune globulin injectionAI (1936 hospitals, 3,020–17,888 samples)
• HCPCS A9503 — Technetium-99m medronate bone scan agentAI (2100 hospitals, 4,998–17,778 samples)
• HCPCS J9043 — Cabazitaxel injection, per 1 mgAI (1783 hospitals, 17,083–17,686 samples)
• HCPCS J7197 — Antithrombin III (human) injection, per unitAI (1666 hospitals, 17,511–17,655 samples)
• HCPCS J0583 — Bivalirudin 250 mg injectionAI (1932 hospitals, 11,437–17,485 samples)
• HCPCS J7298 — Levonorgestrel intrauterine contraceptive device (Mirena)AI (1799 hospitals, 7,108–17,440 samples)
• HCPCS G2212 — Prolonged outpatient or office visitAI (917 hospitals, 13,605–17,169 samples)
• HCPCS J2560 — Phenobarbital sodium injection 65 mg/mLAI (2261 hospitals, 2,699–17,117 samples)
• HCPCS J3105 — Terbutaline sulfate injection, 1 mg/mLAI (2293 hospitals, 2,456–16,964 samples)
• HCPCS A4565 — Small vinyl-coated splint for right wristAI (1433 hospitals, 2,574–16,857 samples)
• HCPCS A9512 — Technetium-99m pertechnetate diagnostic imaging agentAI (1968 hospitals, 15,451–16,729 samples)